Clinical Trials Sponsored by Laboratorio Echevarne

Total 2550 results

Charleston Laboratories, Inc

Completed

A Four-Period, Four-Treatment, Four-Way Relative Bioavailability Study of CL-108 Under Fed and Fasted Conditions

Healthy
Laboratoire Boreaderme Inc.

Unknown

Study of a New Topical Natural Health Product for the Treatment of Herpes Labialis

Herpes Labialis

Canada
Impax Laboratories, LLC

Completed

Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)

Restless Legs Syndrome

United States
Charleston Laboratories, Inc

Completed

Phase III Study of the Safety and Efficacy of Cl-108 in the Treatment of Moderate to Severe Pain

Pain | Nausea | Vomiting

United States
Forest Laboratories
AstraZeneca

Completed

Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)

Infections | Community Acquired Pneumonia

Spain, United States, Argentina, Bulgaria, Georgia, Greece, Hungary, Poland, Ukraine
Romark Laboratories L.C.

Completed

Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C (STEALTHC-2)

Chronic Hepatitis C

United States
Paddock Laboratories, Inc.

Completed

A Study to Compare the Relative Bioavailability of Moexipril HCl/Hydrochlorothiazide in Healthy Adult Volunteers Under Fasting Conditions

Healthy

United States
Fresh Medical Laboratories

Completed

Evaluate the Utility of the ProLung Test as Adjunctive to CT Scan in the Diagnosis of Lung Cancer

Multiple Pulmonary Nodules | Solitary Pulmonary Nodule

United States
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 50 mg

Fasting

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg Under Fasting Condition

Fasting

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg Under Fed Condition

Fasting

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Etodolac Tablet USP 500 mg Under Fed Condition

Fed

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Lisinopril Tablets 40 mg Under Fasting Condition

Fasting

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Lisinopril Tablets 40 mg Under Fed Condition

Fed

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Risperidone Tablet 1 mg Under Fasting Condition

Fasting

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Lamotrigine Tablets 25 mg (2 x 25 mg Tablets) Under Fasting Condition

Fasting State

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Risperidone Tablet 1 mg Under Fed Condition

Fed

India
Forest Laboratories
PPD

Terminated

Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI (ASPECT)

Coronary Artery Disease

United States, Brazil
Forest Laboratories
Phenomix

Terminated

Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin

Diabetes Mellitus, Type II

United States, Belarus, Colombia, Hungary, India, Lithuania, Peru, Romania
Phenomix
Forest Laboratories

Terminated

Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal Impairment

Type 2 Diabetes Mellitus | Renal Impairment

United States, Russian Federation, Ukraine
Coria Laboratories, Ltd.

Completed

Effect of Tetrix on Alleviation of Burning,Itching Associated With Lesions of Contact Dermatitis

Contact Dermatitis

United States
Coria Laboratories, Ltd.

Completed

Evaluation of Tetrix Cream as a Protective Barrier Against Injurious Materials

Healthy

United States
Coria Laboratories, Ltd.

Completed

Study to Determine if Tetrix Cream is Removed From the Hands by Gentle Washing With Soap and Water

Healthy

United States
Ondine Research Laboratories

Unknown

SRP in Combination With PERIOWAVE in Comparison to SRP Alone in Chronic Periodontitis

Periodontitis

United Kingdom
Ondine Research Laboratories

Unknown

Study of Scaling and Root Planing With PerioWave Versus Scaling and Root Planing Alone in Chronic Periodontitis

Periodontitis

Canada
TNO
Laboratoire Oenobiol

Completed

The Effect of 5-Hydroxytryptophan (5-HTP) on Satiety

Obesity

Netherlands
Mekos Laboratories AS

Completed

Clinical Evaluation of Bacitracin

Allergic Contact Dermatitis

United States
Ranbaxy Laboratories Limited
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions

Healthy
Rovi Pharmaceuticals Laboratories

Recruiting

Evaluation of the Pharmacokinetics, Safety, and Tolerability of IM Letrozole LEBE in Healthy Post-menopausal Women (LEILA-1)

Healthy

Czechia
Rovi Pharmaceuticals Laboratories

Recruiting

Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a Relapse (RESHAPE)

Schizophrenia

Germany
Romark Laboratories L.C.

Not yet recruiting

Trial to Evaluate Nitazoxanide for Treatment of Mild COVID-19 in Subjects Not at High Risk of Severe Illness

COVID-19
Dot Laboratories, Inc.

Recruiting

The EMPOWER Study: Endometriosis Diagnosis Using microRNA (EMPOWER)

Endometriosis

United States
Bühlmann Laboratories AG

Recruiting

BÜHLMANN fPELA in the Diagnosis of Exocrine Pancreatic Insufficiency

Exocrine Pancreatic Insufficiency

Germany
Fresh Medical Laboratories

Recruiting

Establish ProLung Test Measurement Collection Protocol for Future Studies.

Cancer , Healthy

United States
Wren Laboratories LLC

Active, not recruiting

Surgical Intervention and the NETest (NETest_Sx)

Neuroendocrine Tumor | Gastroenteropancreatic

Italy
Rovi Pharmaceuticals Laboratories

Completed

Pharmacokinetic, Safety, and Tolerability Study of Risperidone ISM® at Different Dose Strengths (PRISMA-1)

Schizophrenia | Schizoaffective Disorder

Spain, South Africa, Russian Federation, Croatia
Romark Laboratories L.C.

Completed

Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza

Influenza

United States
Neuvosyn Laboratories, LLC

Enrolling by invitation

A Study Evaluation the Safety and Efficacy of Hormone Replacement Therapy With North Star Compared to Levothyroxine in Patients With Primary Hypothyroidism

Hypothyroidism

United States
Charleston Laboratories, Inc

Completed

A Controlled Study to Determine the Efficacy and Safety of CL-108 5 mg for Acute Pain and the Prevention of OINV

Pain | Nausea | Vomiting

United States
Romark Laboratories L.C.

Completed

A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Uncomplicated Influenza

Influenza

United States, Australia, Puerto Rico
Aponia Laboratories, Inc.

Completed

Controlled Study to Assess the Efficacy and Safety of S-Ibuprofen Topical Gel 5% (AP0302) in the Treatment of DOMS

Pain, Acute

United States
Starkey Laboratories, Inc

Completed

Speech Intelligibility in Quiet and Noise for New vs. Legacy Hearing Aids

Hearing Loss | Hearing Loss, Sensorineural

United States
Rovi Pharmaceuticals Laboratories

Completed

Comparative Bioavailability of Risperidone.

Schizophrenia

United States
Rovi Pharmaceuticals Laboratories

Completed

Comparative Bioavailability of Risperidone

Schizophrenia

United States
Nova Laboratories Limited

Completed

Oral Liquid 13-cis-retinoic Acid (13-CRA) (My-CRA)

Neuroblastoma

United Kingdom
Impax Laboratories, LLC

Completed

A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).

Parkinson's Disease

United States, Canada, France, Germany, Poland, Romania, Spain, Ukraine
Impax Laboratories, LLC

Completed

An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease

Parkinson's Disease

United States, Canada, Estonia, Latvia, Lithuania, Romania, Ukraine, Germany, Poland, Spain
Impax Laboratories, LLC

Completed

A Study to Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's Disease

Parkinson's Disease

United States
Impax Laboratories, LLC

Completed

A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease (APEX-PD)

Parkinson's Disease

United States, Canada, Estonia, Latvia, Lithuania, Romania, Ukraine
Fresh Medical Laboratories

Completed

The Effects of Sex, Body Mass Index, Day-to-Day Subject Variability for the ProLung Test and Variability of a Single Device When Volume-Averaged Thoracic Bioconductance is Measured With the ProLung Test

Healthy Volunteers

3

Subscribe